Seroprevalence of SARS-CoV-2 antibodies among blood donors in Taiwan during the initial COVID-19 surge, April–July 2021
Open Access
- 1 May 2026
- journal article
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
Abstract
No abstract availableKeywords
Funding Information
- Taiwan Blood Services Foundation
This publication has 13 references indexed in Scilit:
- Seroprevalence of Anti-SARS-CoV-2 Remained Extremely Low in Taiwan Until the Vaccination Program Was ImplementedOpen Forum Infectious Diseases, 2023
- Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia regionAnnals of Hematology, 2023
- Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021JAMA, 2022
- Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?Vaccine, 2022
- Identification of Natural SARS-CoV-2 Infection in Seroprevalence Studies Among Vaccinated PopulationsMayo Clinic Proceedings, 2022
- Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic WavesJAMA Network Open, 2021
- A seroprevalence study of COVID-19 at a campus in southern TaiwanJournal of Microbiology, Immunology and Infection, 2021
- Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021JAMA, 2021
- The prevalence of antibodies to SARS-CoV-2 among blood donors in ChinaNature Communications, 2021
- Probable Inference, the Law of Succession, and Statistical InferenceJournal of the American Statistical Association, 1927